天臣医疗
(688013)
| 流通市值：19.10亿 | | | 总市值：19.10亿 |
| 流通股本：8115.56万 | | | 总股本：8115.56万 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 65,846,058.15 | 272,367,248.39 | 202,085,550.04 | 132,733,208.3 |
| 营业收入 | 65,846,058.15 | 272,367,248.39 | 202,085,550.04 | 132,733,208.3 |
| 二、营业总成本 | 53,510,478.77 | 224,495,615.38 | 160,735,601.42 | 104,818,196.87 |
| 营业成本 | 27,352,452.67 | 113,066,921.06 | 84,471,120.69 | 55,703,633.15 |
| 税金及附加 | 560,911.61 | 2,715,417.83 | 2,008,911 | 1,045,306.32 |
| 销售费用 | 10,646,011.59 | 39,695,509.57 | 28,349,936.77 | 17,862,077.3 |
| 管理费用 | 8,952,444.57 | 35,198,824.36 | 24,266,542.24 | 15,707,676.8 |
| 研发费用 | 8,771,673.72 | 35,991,857.36 | 24,734,156.26 | 15,572,379.04 |
| 财务费用 | -2,773,015.39 | -2,172,914.8 | -3,095,065.54 | -1,072,875.74 |
| 其中:利息费用 | 36,153.71 | 226,264.3 | 1,412,988.91 | 60,894.83 |
| 其中:利息收入 | 54,951.63 | 2,555,881.37 | 3,156,822.93 | 2,169,801.09 |
| 加:公允价值变动收益 | 1,117,039.83 | -1,891,985.38 | 914,622.22 | 1,569,355.04 |
| 加:投资收益 | 1,316,608.3 | 6,565,162.47 | 3,156,822.93 | 1,732,372.72 |
| 资产减值损失(新) | -206,537.78 | -338,423.76 | -250,087.12 | -205,736.9 |
| 信用减值损失(新) | -361,362.52 | 39,517.05 | -492,405.25 | -428,074.28 |
| 其他收益 | 355,444.38 | 2,751,315.37 | 1,412,988.91 | 553,025.46 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 14,556,771.59 | 54,997,218.76 | 46,091,890.31 | 31,135,953.47 |
| 加:营业外收入 | 9,727.68 | 21,471.94 | 315,308.11 | 256,000 |
| 减:营业外支出 | 8,303.39 | 187,297.4 | 186,399.96 | 186,278.64 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 14,558,195.88 | 54,831,393.3 | 46,220,798.46 | 31,205,674.83 |
| 减:所得税费用 | 1,371,529.93 | 2,936,547.71 | 3,469,090.32 | 2,354,407.81 |
| 六、净利润 | 13,186,665.95 | 51,894,845.59 | 42,751,708.14 | 28,851,267.02 |
| 持续经营净利润 | 13,186,665.95 | 51,894,845.59 | 42,751,708.14 | 28,851,267.02 |
| 归属于母公司股东的净利润 | 13,186,665.95 | 51,894,845.59 | 42,751,708.14 | 28,851,267.02 |
| (一)基本每股收益 | 0.17 | 0.65 | 0.53 | 0.36 |
| (二)稀释每股收益 | 0.16 | 0.64 | 0.53 | 0.36 |
| 八、其他综合收益 | -6,319.87 | 52,395.37 | 7,745.41 | 36,054.29 |
| 归属于母公司股东的其他综合收益 | -6,319.87 | 52,395.37 | 7,745.41 | 36,054.29 |
| 九、综合收益总额 | 13,180,346.08 | 51,947,240.96 | 42,759,453.55 | 28,887,321.31 |
| 归属于母公司股东的综合收益总额 | 13,180,346.08 | 51,947,240.96 | 42,759,453.55 | 28,887,321.31 |
| 公告日期 | 2025-04-28 | 2025-04-28 | 2024-10-30 | 2024-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |